ArticleQuantitative imaging in medicine and surgery2026
Reference values and cut-points for trunk myopenia and myosteatosis in Chinese adults: a secondary analysis of the China Action on Spine and Hip study.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcopenia is a prevalent condition associated with adverse health outcomes, necessitating accurate assessment of skeletal muscle quantity and quality. Computed tomography (CT) is the gold-standard imaging modality for evaluating trunk skeletal muscle area (TrSMA) and density (TrSMD), with opportunistic CT offering a means to assess these metrics without additional radiation exposure. However, the clinical application of CT-based sarcopenia assessment in Chinese populations is hindered by the absence of large-scale, population-specific reference values and cut-off points, particularly for both myopenia (low muscle mass) and myosteatosis (fatty infiltration). This study aims to establish sex- and age-specific percentile reference values and diagnostic cut-off points for CT-derived TrSMA and TrSMD at the L1 and L3 vertebral levels with a large cohort of community-dwelling Chinese adults. Methods: We retrospectively analyzed abdominal CT scans from 4,016 community‑dwelling Chinese adults (21-80 years) across 12 regions. TrSMA and TrSMD at L1 and L3 were segmented using OsiriX. Sex- and age-specific percentile curves were modeled using the lambda-mu-sigma (LMS) method within the generalized additive models for location, scale, and shape (GAMLSS) framework. Estimated age-related differences in TrSMA and TrSMD from ages 25 to 75 years were calculated using LMS-derived medians. Sex‑specific cut‑off points for myopenia and myosteatosis were defined in the 21- to 40-year subgroup using the mean minus two standard deviations (M‑2SD) approach. Results: From ages 25 to 75 years, LMS-derived L1/L3-TrSMA values were lower by 0.45%/0.55% per year in men and 0.33%/0.41% per year in women; corresponding differences in L1/L3-TrSMD were 0.38%/0.35% and 0.55%/0.52% per year. More pronounced age-related decreases were observed in peri- and postmenopausal women and older men. M‑2SD cut‑offs at L1 were 96.0 cm Conclusions: We provide the first CT‑based, sex‑ and age‑specific reference values and cut‑points for trunk myopenia and myosteatosis in Chinese adults, facilitating standardized sarcopenia diagnosis and research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.